Oncolytic designer peptides as an therapy option to treat soft tissue sarcomas

Jennifer Hauk, Frank Jacobsen, Cornelius Schubert, Stefan Langer, Ingo Stricker, Sammy Al-Benna, Yechiel Shai, Hans-Ulrich Steinau & Lars Steinstraesser
Introduction: Soft tissue sarcoma (STS) is an anatomically and histologically heterogeneous neoplasia that shares a putative mesenchymal cell origin. The treatment with common chemotherapeutics is still unsatisfying because of association with poor response rates. Although evidence is accumulating for[for full text, please go to the a.m. URL]